Moxidectin: an ally to ivermectin for treating Strongyloides stercoralis?

Lancet Infect Dis. 2021 Aug;21(8):1060-1061. doi: 10.1016/S1473-3099(20)30718-0. Epub 2021 Mar 30.

Authors

Zeno Bisoffi¹, Dora Buonfrate²

Affiliations

¹ Department of Infectious Tropical diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Verona 37024, Italy; Department of Diagnostics and Public Health, University of Verona, Verona, Italy. Electronic address: zeno.bisoffi@univr.it.
² Department of Infectious Tropical diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Verona 37024, Italy.

PMID: 33798488
DOI: 10.1016/S1473-3099(20)30718-0

No abstract available

Publication types

Comment

MeSH terms

Animals
Humans
Ivermectin / therapeutic use
Macrolides / therapeutic use
Strongyloides stercoralis*
Strongyloidiasis* / drug therapy

Substances

Macrolides
Ivermectin
moxidectin